Samsrita Labs Ltd

Samsrita Labs Q1 FY27 Results: Net Loss of ₹0.2 Cr

Samsrita Labs Ltd reported a net loss of ₹0.2 Cr for Q1 FY27.

Key figure

Net loss ₹0.2 Cr

Samsrita Labs Annual General Meeting

Samsrita Labs Limited held its 30th Annual General Meeting on August 10, 2026. The meeting proceedings and agenda were successfully conducted via video conferencing.

Samsrita Labs Board Meeting Date

Samsrita Labs Limited has scheduled a board meeting for August 13, 2026. The board will consider and approve un-audited financial results for the quarter ended June 30, 2026.

Samsrita Labs Other Announcement

Samsrita Labs Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with Regulation 31(1)(b).

Samsrita Labs Annual General Meeting

Samsrita Labs Limited has scheduled its Annual General Meeting for August 10, 2026. The agenda includes financial statement adoption and a Material Related Party Transaction.

Value

₹15.00 Cr

Samsrita Labs Annual General Meeting

Samsrita Labs Limited has scheduled its 30th Annual General Meeting for August 10, 2026. The filing provides the AGM notice and Annual Report for FY 2025-26.

Samsrita Labs Board Meeting Outcome

Samsrita Labs announced a board‑approved capital reduction cancelling 1,13,74,855 shares, lowering paid‑up capital to ₹11.37 crore. The move aims to offset accumulated losses.

Value

₹11.37 Cr

Samsrita Labs Management Change

SamSrita Labs appointed Mr. Satyanarayana Murthy Varanasi as Non-Executive Independent Director. Term is 60 months, effective July 4, 2026.

Samsrita Labs Board Meeting Outcome

Samsrita Labs Ltd's board approved a capital reduction scheme and appointed a new director. The AGM is scheduled for August 10, 2026.

Samsrita Labs Board Meeting Date

Samsrita Labs scheduled a board meeting for July 4, 2026. The board will consider a draft scheme for share capital re-organisation.

Samsrita Labs Other Announcement

Samsrita Labs Limited submitted its Annual Secretarial Compliance Report for the financial year 2026. The report by Manoj Parakh & Associates indicates overall statutory compliance with SEBI regulations.

Samsrita Labs Fund Raise of ₹3.39 Cr

Samsrita Labs Limited reported zero deviation in the utilization of ₹3.39 Crore raised through a preferential issue. The Audit Committee reviewed these findings on May 29, 2026.

Value

₹3.39 Cr

Samsrita Labs Q4 FY26 Results: Net Loss of ₹0.5 Cr

Samsrita Labs Ltd reported a net loss of ₹0.5 Cr for Q4 FY26.

Key figure

Net loss ₹0.5 Cr

Samsrita Labs Financial Results

Samsrita Labs reported audited FY26 results showing standalone total income of ₹4.96 Lakhs. The Board also approved internal auditor appointments and bad debt write-offs.

Samsrita Labs Board Meeting Date

Samsrita Labs Limited scheduled a Board Meeting on May 29, 2026, to approve audited financial results. The trading window remains closed for designated persons until June 1.

Samsrita Labs Debt & Borrowing

Samsrita Labs Limited submitted its annual disclosure confirming it does not qualify as a Large Corporate under SEBI framework for FY 2025-26. The company reported zero incremental borrowings and no penalties for the period. This routine regulatory filing maintains compliance with debt-raising norms for listed entities.

Samsrita Labs Debt & Borrowing

Samsrita Labs Limited (BSE: 539267) confirmed it does not qualify as a Large Corporate for FY 2026. The company reported zero outstanding borrowings as of March 31, 2026, exempting it from mandatory incremental borrowing through debt securities under SEBI framework.

Samsrita Labs Price Movement Clarification

Samsrita Labs Limited clarified to BSE that recent share price movement is purely market-driven. The company confirmed it has disclosed all price-sensitive information as per SEBI regulations and has not withheld any material news. Management maintains its commitment to timely regulatory disclosures.